Business Wire

31. bioAffinity Technologies And Pictor, Inc. Partner To Develop And Commercialize Bioaffinity's Diagnostics For Asthma And COPD 7/22/2026
32. Cancer Cell Diagnostics (CCDx) Debuts Whole-Cell Genomic Profiling To Redefine Liquid Biopsy 7/22/2026

    Cancer Cell Diagnostics today announced the commercial launch of its CellSight DNA comprehensive genomic profiling test. This test is built on a fundamentally distinct source material from conventional liquid biopsy.

33. Seek Labs Announces Publication In Nature Communications Validating ANINA™, A Room-Temperature, Instrument-Free Amplification Diagnostic Technology Designed To Deliver PCR-Level Sensitivity At The Point Of Need 7/21/2026

    Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, announced the publication of a peer-reviewed manuscript in Nature Communications describing Annexing Isothermal Nucleotide Amplification (ANINA), the proprietary amplification chemistry that powers its SeekIt molecular diagnostic platform.

34. UnitedHealth Group Now Covers Guardant Health's Shield Blood Test For Colorectal Cancer Screening 7/1/2026

    Guardant Health, Inc., a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group (UHG) members¹, making it the first major commercial insurer to provide coverage for adults 45 or older amid rising CRC rates for adults under 652 and mortality for younger adults as the leading cause of cancer death for those under 50.³

35. Idengene SA To Bring Contextual Genomics' Revolutionary Cancer Genomic Test Find-It To Brazil 11/9/2017

    Brazilian diagnostics company Idengene SA has partnered with leading Canadian cancer genomics company Contextual Genomics to bring Find-It™, a potentially revolutionary genomic test, to Brazil. Idengene will offer Find-It™ at its laboratory in Brazil to patients diagnosed with cancer

36. New Benchtop Centrifuge Incorporates Hybrid Rotor For Application Flexibility 2/4/2016

    Clinical and life science researchers can now benefit from a new benchtop centrifuge that features a unique 2-in-1 hybrid rotor that has interchangeable fixed-angle and swinging buckets to facilitate quick and convenient switching between applications

37. First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation 5/13/2015

    The first patient with atrial fibrillation (AF) has been enrolled in the global RE-CIRCUIT™ study.⁴ The study assesses the safety and efficacy of uninterrupted anticoagulation with dabigatran etexilate (Pradaxa^®) during ablation procedures compared to warfarin.¹ Results from the RE-CIRCUIT™ study are expected during 2016

38. Thermo Fisher Scientific Releases New CE-IVD Tumor Panel For Next Generation Sequencing 1/13/2015

    The newly released CE-IVD Oncomine Solid Tumor DNA kit from Thermo Fisher Scientific enables highly accurate and reliable multiplexed sequencing of formalin-fixed, paraffin embedded (FFPE) tumor samples with the quality and performance needed for the clinical laboratory

39. One Lambda Announces The Availability Of Its New RUO NXType Kit, A Complete Solution For HLA Typing By NGS 12/1/2014

    One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of research and in vitro diagnostic products for the HLA transplant community, recently launched its RUO NXType Kit, a research use only (RUO) solution for human leukocyte antigen (HLA) typing by next-generation sequencing (NGS)

40. AB SCIEX Launches Next-Generation TripleTOF 5600 System 5/21/2012

    AB SCIEX, a global leader in life science analytical technologies, recently announced the launch of the second generation of the TripleTOF 5600 System.